SPY333.79-0.71 -0.21%
DIA278.79-0.11 -0.04%
IXIC10,877.64-32.63 -0.30%

Roth Capital Initiates Coverage On Ampio Pharmaceuticals with Buy Rating, Announces $4 Price Target

Roth Capital analyst Jonathan Aschoff initiates coverage on Ampio Pharmaceuticals (AMEX:AMPE) with a Buy rating and a $4 price target.

Benzinga · 12/19/2019 11:38

Roth Capital analyst Jonathan Aschoff initiates coverage on Ampio Pharmaceuticals (AMEX:AMPE) with a Buy rating and a $4 price target.